DOI: 10.1111/apt.14060 , PMID: 28417494 Issn Print: 0269-2813 Publication Date: 2017/05/01 Print Editorial: CT‐P13, a biosimilar of anti‐tumour necrosis factor‐alpha agent (infliximab), in inflammatory bowel diseases – authors’ reply Y. Komaki; A. Yamada; F. Komaki; D. Micic; A. Ido; A. Sakuraba + Author Information Author Information: Section of Gastroenterology, Hepatology and Nutrition Checking for direct PDF access through Ovid View on Journal Site Abstract Abstract unavailable for this article.
